Status:
COMPLETED
Treatment Follow-up Study
Lead Sponsor:
Nationwide Children's Hospital
Collaborating Sponsors:
Agency for Healthcare Research and Quality (AHRQ)
Conditions:
Interactive Voice Response (IVR)
Eligibility:
All Genders
6-17 years
Phase:
PHASE2
Brief Summary
This study will assess the effectiveness of a medication safety monitoring method utilizing interactive voice response technology for youth recently prescribed anti-depressant medication.
Detailed Description
Over a two year period, 800 children and adolescents between the ages of 6 - 17 years old who have received a new prescription for an antidepressant will be recruited from families receiving care at N...
Eligibility Criteria
Inclusion
- Over a two year period, 800 children and adolescents aged 6 - 17 years old who have received a new prescription for an antidepressant will be recruited from families receiving care at Nationwide Children's Hospital or Community Physician Practices affiliated with Nationwide Children's Hospital. It should be noted that we are not requiring this to be the first antidepressant prescription a patient has received.
Exclusion
- Families who speak do not speak English and families with children who are actively psychotic.
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2011
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT00995696
Start Date
September 1 2008
End Date
May 1 2011
Last Update
June 22 2011
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Nationwide Children's Hospital
Columbus, Ohio, United States, 43205
2
The Ohio State University
Columbus, Ohio, United States, 43210